SCYNEXIS, Inc. (SCYX)

Current price	$1.25
Prev. close	$1.28
Day low	$1.24
Day high	$1.29
50-day MA	$1.45
200-day MA	$1.63
52-week high	$2.50
52-week low	$1.05
Volume	261,086
Avg. volume	478,273
Dividend yield	N/A
Market Cap	58.76M

SCYX Social Stream

View Full SCYX Social Stream

SCYX Returns

1-mo	-8.76%
3-mo	-26.90%
6-mo	-10.71%
1-year	-47.26%
3-year	-82.07%
5-year	N/A

YTD	-46.12%
2017	-27.27%
2016	-48.63%
2015	-37.78%
2014	N/A
2013	N/A

SCYNEXIS, Inc. (SCYX) Company Bio

SCYNEXIS, Inc., a pharmaceutical company, develops and commercializes novel anti-infectives to address unmet therapeutic needs. Its lead product candidate includes SCY-078, which is in Phase I clinical trials of the intravenous formulation; Phase II clinical trials for the treatment of invasive candida infections; and Phase II clinical trials for unmet medical needs, such as vulvovaginal candidiasis. The company was founded in 1999 and is based in Jersey City, New Jersey.

SCYNEXIS, Inc. (SCYX)

SCYX - Live POWR Rating™

Overall POWR Rating

SCYX - POWR Components

SCYX News Stream

SCYX Stock Chart More Charts

SCYX Price/Volume Stats

SCYX Social Stream

SCYX Returns

SCYNEXIS, Inc. (SCYX) Company Bio

Top Stories View All

Twitter, Inc (TWTR) Rushed to Patch a Bug That May Have Shares Private DMs

Analyst Bullish on Road Ahead for Exxon Mobil (XOM)

Analyst: Advanced Micro Devices (AMD) Has Shot to Triple Market Share vs. Intel

Amazon, Inc. (AMZN) Leaps Past Apple for Smart Home Dominance

Walmart Inc (WMT) Will Have a Tough Time Maintaining Low Prices Because of Tariff Consequences